>
Switch to:

Cara Therapeutics Enterprise Value

: $494.0 Mil (As of Today)
View and export this data going back to 2014. Start your Free Trial

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cara Therapeutics's Enterprise Value is $494.0 Mil. Cara Therapeutics's EBIT for the trailing twelve months (TTM) ended in Mar. 2021 was $11.8 Mil. Therefore, Cara Therapeutics's EV-to-EBIT ratio for today is 41.78.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Cara Therapeutics's Enterprise Value is $494.0 Mil. Cara Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2021 was $12.0 Mil. Therefore, Cara Therapeutics's EV-to-EBITDA ratio for today is 41.00.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Cara Therapeutics's Enterprise Value is $494.0 Mil. Cara Therapeutics's Revenue for the trailing twelve months (TTM) ended in Mar. 2021 was $128.9 Mil. Therefore, Cara Therapeutics's EV-to-Revenue ratio for today is 3.83.


Cara Therapeutics Enterprise Value Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cara Therapeutics Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Enterprise Value Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 195.31 307.22 352.74 601.98 578.92

Cara Therapeutics Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Enterprise Value Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 501.16 675.16 479.56 578.92 919.42

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Cara Therapeutics Enterprise Value Distribution

* The bar in red indicates where Cara Therapeutics's Enterprise Value falls into.



Cara Therapeutics Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Cara Therapeutics's Enterprise Value for the fiscal year that ended in Dec. 2020 is calculated as

Cara Therapeutics's Enterprise Value for the quarter that ended in Mar. 2021 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cara Therapeutics  (NAS:CARA) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Cara Therapeutics's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=493.993/11.825
=41.78

Cara Therapeutics's current Enterprise Value is $494.0 Mil.
Cara Therapeutics's EBIT for the trailing twelve months (TTM) ended in Mar. 2021 was -25.884 (Jun. 2020 ) + -17.02 (Sep. 2020 ) + 78.29 (Dec. 2020 ) + -23.561 (Mar. 2021 ) = $11.8 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Cara Therapeutics's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=493.993/12.049
=41.00

Cara Therapeutics's current Enterprise Value is $494.0 Mil.
Cara Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2021 was -25.836 (Jun. 2020 ) + -16.969 (Sep. 2020 ) + 78.352 (Dec. 2020 ) + -23.498 (Mar. 2021 ) = $12.0 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Cara Therapeutics's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=493.993/128.924
=3.83

Cara Therapeutics's current Enterprise Value is $494.0 Mil.
Cara Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2021 was 5.634 (Jun. 2020 ) + 9.266 (Sep. 2020 ) + 112.089 (Dec. 2020 ) + 1.935 (Mar. 2021 ) = $128.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cara Therapeutics Enterprise Value Related Terms


Cara Therapeutics Enterprise Value Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)